Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Note: The Daily Option Update is provided by Options Specialist Paul Foster of theflyonthewall.com.
Volatility Index S&P 500 Options-VIX down .35 to 11.10.
AtheroGenics Inc. (NASDAQ:AGIX) derivatives high risk, option volume up traders prepare for data. AtheroGenics focuses on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases. AtheroGenics is expected to announce results for top line data from the ARISE Phase 3 trial on AGI-1067 (coronary heart disease treatment.) AGIX said on 1/8/07 the data "will likely be available no sooner than late first quarter." AtheroGenics call option volume of 27,881 contracts compares to put volume of 14,119 contracts. AtheroGenics April 12.5 straddle is at $11 dollars, according to Track Data, suggesting large risks.
Option volume leaders today were: Motorola Inc. (NYSE:MOT), Apple, Inc.(NASDAQ:AAPL), CountryWide Financial Corp. (NYSE:CFC), Caterpillar Inc. (NYSE:CAT) and U.S. Steel Corp. (NYSE:X).
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
